Effects of one-year treatment with canagliflozin or sitagliptin on glycaemic control and beta cell function measures in subjects with type 2 diabetes on metformin plus sulfonylurea

被引:0
|
作者
Schernthaner, G. [1 ]
Ferrannini, E. [2 ]
Mari, A. [3 ]
Tong, C. [4 ]
Kawaguchi, M. [4 ]
Meininger, G. [4 ]
Polidori, D. [4 ]
机构
[1] Rudolfstiftung Hosp Vienna, Vienna, Austria
[2] Univ Pisa, Sch Med, I-56100 Pisa, Italy
[3] CNR, Inst Biomed Engn, Padua, Italy
[4] Janssen R&D LLC, Raritan, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
993
引用
收藏
页码:S398 / S399
页数:2
相关论文
共 50 条
  • [41] Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
    Mo, Dan
    Liu, Songfang
    Ma, Hong
    Tian, Haoming
    Yu, Honglin
    Zhang, Xiangxun
    Tong, Nanwei
    Liao, Jiayu
    Ren, Yan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2769 - 2776
  • [42] One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study
    Marco Zavattaro
    Marina Caputo
    Maria Teresa Samà
    Chiara Mele
    Luisa Chasseur
    Paolo Marzullo
    Loredana Pagano
    Maria Grazia Mauri
    Maria Chantal Ponziani
    Gianluca Aimaretti
    Flavia Prodam
    Endocrine, 2015, 50 : 620 - 626
  • [43] One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study
    Zavattaro, Marco
    Caputo, Marina
    Sama, Maria Teresa
    Mele, Chiara
    Chasseur, Luisa
    Marzullo, Paolo
    Pagano, Loredana
    Mauri, Maria Grazia
    Ponziani, Maria Chantal
    Aimaretti, Gianluca
    Prodam, Flavia
    ENDOCRINE, 2015, 50 (03) : 620 - 626
  • [45] Effects of dulaglutide and trelagliptin on beta cell function after one year in patients with type 2 diabetes: DUET-beta extension study
    Kondo, Y.
    Satoh, S.
    Terauchi, Y.
    DIABETOLOGIA, 2019, 62 : S379 - S380
  • [46] Beta-Cell Function and Glycemic Control Following One-Year Vildagliptin Treatment, and after 12-Week Washout, in Drug-Naive Patients with Type 2 Diabetes and Mild Hyperglycemia
    Bunck, Mathijs C.
    Poelma, Marieke
    Goede, Diane L.
    Van Golen, Larissa W.
    Van Genugten, Renate E.
    Eekhoff, E. Marelise
    Schweizer, Anja
    Heine, Robert J.
    Foley, James E.
    Nijpels, Giel
    Diamant, Michaela
    DIABETES, 2010, 59 : A17 - A17
  • [47] Effect of Basal Insulin Plus Oral Antidiabetes Drug Therapy on beta-Cell Function and Glycaemic Control in Patients with Newly Diagnosed Type 2 Diabetes
    Mu, Pan-Wei
    Zeng, Long-Yi
    Chen, Yan-Ming
    Lu, Hong-Yun
    Wen, Xing-Qiao
    Zhang, Guo-Chao
    Xie, Ru-Ying
    Wang, Man-Man
    Shu, Jiong
    DIABETES, 2011, 60 : A288 - A288
  • [48] One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial
    Pratley, R.
    Nauck, M.
    Bailey, T.
    Montanya, E.
    Cuddihy, R.
    Filetti, S.
    Garber, A.
    Thomsen, A. B.
    Hartvig, H.
    Davies, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (04) : 397 - 407
  • [49] Saxagliptin Is More Effective in β-Cell Function and Glycaemic Control than Acarbose in Aged Type 2 Diabetes Controlled Inadequately with Metformin Alone
    Wang, Man-Man
    Mu, Pan-Wei
    Zhang, Yong-Jun
    Lin, Shuo
    Chen, Yan-Ming
    Shu, Jiong
    Zeng, Long-Yi
    DIABETES, 2014, 63 : A613 - A613
  • [50] The effects of once-weekly semaglutide on beta-cell function in subjects with type 2 diabetes
    Kapitza, Christoph
    Dahl, Kirsten
    Jacobsen, Jacob Bonde
    Axelsen, Mads Buhl
    Bergan, Eirik Quamme
    Flint, Anne
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S127 - S128